AzTrials
AzTrials

FrailtyNCT03394534

Comprehensive Geriatric Assessment in Primary Care: A Randomised Feasibility Trial

A study testing CGA group in people with Frailty, run by University of Derby at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims to explore feasibility of implementing a tailored CGA to older adults with frailty and evaluate staff and patients perception of the intervention. In line with this, the objectives of the study are: 1. Read more about this study

Who is it for?
Ages 65 to 95 years
Conditions the study is for
Frailty
What is being tested?
CGA group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteUnited Kingdom
Study dates
15 Jan 2019to 30 Sep 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 95 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Age 65 to 95 years
  • eFI score > 0.12

Who cannot join

  • Do not meet criteria for frailty based on Gait speed, timed up and go test and PRISMA questionnaire

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University of Derby

    Derby, DE22 1GB

Other trials in United Kingdom

About this study

Official title: 'Comprehensive Geriatric Assessment' for Older Adults With Frailty Within Primary Care Setting: A Randomised Feasibility Trial

The study aims to explore feasibility of implementing a tailored CGA to older adults with frailty and evaluate staff and patients perception of the intervention. In line with this, the objectives of the study are:

  1. To assess applicability of finding older adults with frailty using eFI and delivering subsequent CGA and care planning at patients' home
  2. To investigate staff and older adults' perception of CGA programme
  3. To assess the health care resource usage and cost of the CGA programme
  4. To measure key health related outcome domains including function, quality of life, loneliness, pain, falls and mobility.
Conditions
Frailty
Being tested
CGA group
Keywords
Comprehensive Geriatric Assessment, Frailty, electronic Frailty Index, eFI, Care and Support plan, Primary Care
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CGA groupOther

    CGA Plus Individualised Care and Support Plan delivered by Advanced Clinical Practitioner (ACP)

Study groups in NCT03394534
Study groupRoleWhat they receive
CGA groupExperimentalNot described
Receives: Other: CGA group
Treatment as UsualNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hospitalisation and Nursing Home Admissions

    Number of hospital and/or care home admissions during the 6 months period and reported in terms of admitted v. not admitted

    Measured: at 6 months post intervention

Secondary outcomes (8)
  1. Functional Status

    Improve Patient functional ability measured using Functional Independence Measure (FIM) questionnaire total score

    Measured: at baseline and 6 months post intervention

  2. Loneliness

    Improve overall, emotional, and social loneliness calculated using the De Jong Gierveld Loneliness Scale total score. The scale is used to assess subjective perception of social participation or isolation in elderly adults.

    Measured: at baseline and 6 months post intervention

  3. Health related Quality of Life

    Change in health related quality of life calculated using the 36-Item Short Form Survey (SF-36). The Sf-36 is patient reported outcome measure with a set of generic quality of life measures including vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, mental health subscales.

    Measured: at baseline and 6 months post intervention

  4. Number of 999 calls and A+E attendance during the 6 months period

    Measured: at 6 months post intervention

  5. Length of time spent on A+E during the 6 months period

    Measured: at 6 months post intervention

  6. Length of time stayed in hospital or care home during the 6 months period

    Measured: at 6 months post intervention

  7. Therapist and staff time spent on CGA during the 6 months period

    Measured: at 6 months post intervention

  8. Number of GP/GP out of office attendance (including calls to GP) during the 6 months period

    Measured: at 6 months post intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2018
  2. Study start15 Jan 2019
  3. Primary completion15 Jun 2019
  4. Study completion30 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03394534
Sponsor's protocol ID
v3.6
Status last verified
May 2022
First submitted
18 Dec 2017
Last updated
18 May 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Edmans J, Bradshaw L, Gladman JR, Franklin M, Berdunov V, Elliott R, Conroy SP. The Identification of Seniors at Risk (ISAR) score to predict clinical outcomes and health service costs in older people discharged from UK acute medical units. Age Ageing. 2013 Nov;42(6):747-53. doi: 10.1093/ageing/aft054. Epub 2013 May 10.

    PubMed 23666405
  • Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013 Mar 2;381(9868):752-62. doi: 10.1016/S0140-6736(12)62167-9. Epub 2013 Feb 8.

    PubMed 23395245
  • Gladman JR, Conroy SP, Ranhoff AH, Gordon AL. New horizons in the implementation and research of comprehensive geriatric assessment: knowing, doing and the 'know-do' gap. Age Ageing. 2016 Mar;45(2):194-200. doi: 10.1093/ageing/afw012.

    PubMed 26941353
  • Fit for Frailty - Developing, commissioning and managing services for people living with frailty in community settings - a report from the British Geriatrics Society and the Royal College of General Practitioners 2015.

  • Clegg A, Rogers L, Young J. Diagnostic test accuracy of simple instruments for identifying frailty in community-dwelling older people: a systematic review. Age Ageing. 2015 Jan;44(1):148-52. doi: 10.1093/ageing/afu157. Epub 2014 Oct 29.

    PubMed 25355618
  • Safari R, Jackson J, Boole L. Comprehensive geriatric assessment delivered by advanced nursing practitioners within primary care setting: a mixed-methods pilot feasibility randomised controlled trial. BMC Geriatr. 2023 Aug 24;23(1):513. doi: 10.1186/s12877-023-04218-0.

    PubMed 37620760

Questions about this trial

What is this clinical trial studying?

A study testing CGA group in people with Frailty, run by University of Derby at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hospitalisation and Nursing Home Admissions (time frame: at 6 months post intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03394534, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in